AU772653B2 - Use of poly(diallylamine) polymers - Google Patents

Use of poly(diallylamine) polymers Download PDF

Info

Publication number
AU772653B2
AU772653B2 AU12893/01A AU1289301A AU772653B2 AU 772653 B2 AU772653 B2 AU 772653B2 AU 12893/01 A AU12893/01 A AU 12893/01A AU 1289301 A AU1289301 A AU 1289301A AU 772653 B2 AU772653 B2 AU 772653B2
Authority
AU
Australia
Prior art keywords
polymer
poly
diallylamine
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU12893/01A
Other languages
English (en)
Other versions
AU1289301A (en
Inventor
Keith Moray Blackwood
John William Goodby
Alan William Hall
Paul Edward Young Milne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qinetiq Ltd
Original Assignee
Qinetiq Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qinetiq Ltd filed Critical Qinetiq Ltd
Publication of AU1289301A publication Critical patent/AU1289301A/en
Application granted granted Critical
Publication of AU772653B2 publication Critical patent/AU772653B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0605—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • C08G73/0611—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring, e.g. polypyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G61/12—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU12893/01A 1999-11-17 2000-11-10 Use of poly(diallylamine) polymers Ceased AU772653B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9927088.6A GB9927088D0 (en) 1999-11-17 1999-11-17 Use of poly(diallylamine) polymers
GB9927088 1999-11-17
PCT/GB2000/004308 WO2001036510A2 (en) 1999-11-17 2000-11-10 Use of poly(diallylamine) polymers

Publications (2)

Publication Number Publication Date
AU1289301A AU1289301A (en) 2001-05-30
AU772653B2 true AU772653B2 (en) 2004-05-06

Family

ID=10864611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12893/01A Ceased AU772653B2 (en) 1999-11-17 2000-11-10 Use of poly(diallylamine) polymers

Country Status (9)

Country Link
US (1) US7767229B1 (cg-RX-API-DMAC7.html)
EP (1) EP1265942B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003514935A (cg-RX-API-DMAC7.html)
AT (1) ATE287911T1 (cg-RX-API-DMAC7.html)
AU (1) AU772653B2 (cg-RX-API-DMAC7.html)
CA (1) CA2391539C (cg-RX-API-DMAC7.html)
DE (1) DE60017805T2 (cg-RX-API-DMAC7.html)
GB (1) GB9927088D0 (cg-RX-API-DMAC7.html)
WO (1) WO2001036510A2 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606016D0 (en) * 2006-03-25 2006-05-03 Ionic Polymer Solutions Ltd Quaternary ammonium compounds and their uses
GB0613013D0 (en) 2006-06-30 2006-08-09 Novel Polymer Solutions Ltd Polymeric Materials and Methods for Manufacturing Them
DE102010002141A1 (de) 2010-02-19 2011-08-25 Momentive Performance Materials GmbH, 51373 Integrale Bestrahlungseinheit
EP2601272B8 (en) 2010-08-02 2015-02-25 Syntor Specialty Chemicals Limited Composite articles and methods of producing same
WO2012017235A1 (en) 2010-08-02 2012-02-09 Novel Polymer Solutions Limited Covered floors and methods of adhering flooring to a floor
EP2601047B8 (en) 2010-08-02 2015-02-25 Syntor Specialty Chemicals Limited Methods of coating a low surface energy substrate
LT3023102T (lt) 2010-11-04 2018-09-25 Albireo Ab Ibat inhibitoriai, skirti kepenų ligų gydymui
GB201105453D0 (en) 2011-03-31 2011-05-18 Novel Polymer Solutions Ltd Window frames, structural elements for a roofed construction and methods of assembling same
KR20140054058A (ko) 2011-08-18 2014-05-08 모멘티브 퍼포먼스 머티리얼즈 게엠베하 조사 및 성형 유닛
GB201115823D0 (en) 2011-09-13 2011-10-26 Novel Polymer Solutions Ltd Mineral processing
CN104640681B (zh) 2012-06-11 2017-11-17 迈图高新材料集团 用于制备塑料复合成型体的方法
KR20210131457A (ko) 2013-06-05 2021-11-02 트리시다, 인크. 경구 투여를 위한 양성자-결합 중합체
KR20220082931A (ko) 2014-06-25 2022-06-17 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
ES2787218T3 (es) 2014-12-10 2020-10-15 Tricida Inc Polímeros de unión de protones para la administración oral
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
EP3452028A4 (en) 2016-05-06 2020-04-15 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS
CA3071285A1 (en) 2017-08-09 2019-02-14 Albireo Ab Cholestyramine granules, oral cholestyramine formulations and use thereof
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
SG11202003451UA (en) 2017-11-03 2020-05-28 Tricida Inc Compositions for and method of treating acid-base disorders
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
PL3810581T3 (pl) 2018-06-20 2025-04-28 Albireo Ab Modyfikacje kryształu odewiksibatu
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
SMT202300020T1 (it) 2019-02-06 2023-03-17 Albireo Ab Composti di benzotiadiazepine e loro uso come modulatori degli acidi biliari
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
CA3158276A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
CR20220315A (es) 2019-12-04 2022-10-26 Albireo Ab Compuestos de benzoti(di)azepina y su uso como moduladores del ácido biliar
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN114761018B (zh) 2019-12-04 2025-12-02 阿尔比里奥公司 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
EP4188541B1 (en) 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
CA3196488A1 (en) 2020-11-12 2022-05-19 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
EP4255565A1 (en) 2020-12-04 2023-10-11 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE520401A (cg-RX-API-DMAC7.html) * 1952-06-03
US3957699A (en) 1973-06-12 1976-05-18 Ici Australia Limited Process for polymerizing allylamines employing a redox initiator consisting of Fe++ or Ti+++ with H2 O2, hydroxyl amine, or hydroperoxides to form insoluble crosslinked polymers
US4121986A (en) * 1975-05-07 1978-10-24 Ici Australia Limited Process for the polymerization of polyallylamines in the presence of a mineral acid solution
JPS5747302A (en) * 1980-09-03 1982-03-18 Mitsubishi Petrochem Co Ltd Preparation of crosslinkable electrolytic polymer
JPS62257481A (ja) * 1986-04-30 1987-11-10 三洋化成工業株式会社 染料固着剤
US4759923A (en) * 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
JPH021358A (ja) * 1988-03-01 1990-01-05 Sanyo Chem Ind Ltd インクジェット記録紙用薬剤
US6203785B1 (en) * 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
SG85658A1 (en) * 1998-07-02 2002-01-15 Nat Starch Chem Invest Package encapsulants prepared from allylated amide compounds
SG105450A1 (en) * 1998-07-02 2004-08-27 Nat Starch Chem Invest Allylated amide compounds and die attach adhesives prepared therefrom
GB9816171D0 (en) * 1998-07-25 1998-09-23 Secr Defence Monomers and network polymers obtained therefrom
GB9816167D0 (en) * 1998-07-25 1998-09-23 Secr Defence Polymer production

Also Published As

Publication number Publication date
CA2391539A1 (en) 2001-05-25
DE60017805T2 (de) 2006-01-12
CA2391539C (en) 2009-08-11
AU1289301A (en) 2001-05-30
US7767229B1 (en) 2010-08-03
DE60017805D1 (de) 2005-03-03
WO2001036510A2 (en) 2001-05-25
ATE287911T1 (de) 2005-02-15
EP1265942B1 (en) 2005-01-26
GB9927088D0 (en) 2000-01-12
JP2003514935A (ja) 2003-04-22
WO2001036510A3 (en) 2002-09-12
EP1265942A2 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
AU772653B2 (en) Use of poly(diallylamine) polymers
EP2175866B1 (en) Novel one step process for preparing cross-linked poly(allylamine) polymers
US8852640B2 (en) Micelles for delivery of nitric oxide
JP2003514935A5 (cg-RX-API-DMAC7.html)
AU2006292752A1 (en) Polymeric compositions and methods of making and using thereof
CN101402737B (zh) 可降解导电生物医用高分子材料
CN113456827B (zh) 一种纳米材料及其制备方法和应用
CN102091025B (zh) 抗肿瘤可注射水凝胶及其制备方法和用途
JP4465193B2 (ja) リン酸塩輸送インヒビター
NZ530588A (en) Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
Karmakar et al. Synthesis of RAFT‐mediated amphiphilic graft copolymeric micelle using dextran and poly (oleic acid) toward Oral delivery of Nifedipine
CN118047959A (zh) 一种聚乙二醇水凝胶材料及其制备方法与应用
CN116554510A (zh) 一种碘基纳米造影剂的制备方法
CN101265331A (zh) Peg改性phpma材料及其制备方法
CN101067015A (zh) 聚肽－聚丙烯酸类共聚物及其制备方法
US10618998B2 (en) Poly(alkylene carbonate)-based amphiphilic block copolymers and methods of use thereof
JPS58149903A (ja) ネオカルチノスタチン複合体の製造法
CN106580920B (zh) 一种具有强耐盐能力的智能型胰岛素递送体系及制备工艺
JP6654057B2 (ja) 局所麻酔薬を含有するポリイオンコンプレックスを有効成分とする局所疼痛制御用組成物
CN117720734B (zh) 聚乙二醇单甲醚-衣康酸基聚酯-聚乙二醇单甲醚两亲性嵌段共聚物及其制备方法和应用
CN116023577A (zh) 一种双亲性的含铜聚合物纳米粒子及其制备与应用
JP4699635B2 (ja) 徐放性薬剤組成物
CN108383959A (zh) 一种pH/温度双重敏感的两亲性四臂星型聚合物及制备方法与应用
Li Complex nanoscopic objects from well-defined polymers that contain functional units
JPH05238955A (ja) 生理活性ペプチドの安定化方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)